Largest Biotechnology Companies by Market Cap
The Biotechnology sector has 1,293 publicly listed stocks with a combined market cap of $2.10 Trillion. Puma Biotechnology Inc leads the sector with a market cap of $382.08 Million. This ranking covers all Biotechnology stocks globally — from large-cap industry leaders to mid-cap and small-cap companies — ranked by market capitalization and updated daily.
Total Market Cap (USD)
$2.10 Trillion
Companies Listed
1,293
Largest Company
Puma Biotechnology Inc
| Rank | Company | Market Cap (USD) | Market Cap (Local) | Country | Price | 24h Change | 7d Change | 24h Volume |
|---|---|---|---|---|---|---|---|---|
| 451 |
Puma Biotechnology Inc
NASDAQ:PBYI |
$382.08 Million | $382.08 Million | USA | $9.25 | +1.20% | -3.14% | 6.97 Million |
| 452 |
Yantai Zhenghai Bio-Tech Co Ltd
SHE:300653 |
$381.93 Million | CN¥2.61 Billion | China | CN¥14.50 | -2.16% | -4.10% | 60.08 Million |
| 453 |
Scribe Therapeutics Inc. Common Stock
NASDAQ:SCTX |
$379.31 Million | $379.31 Million | USA | $31.66 | +7.61% | +10.43% | 5.33 Million |
| 454 |
Vigil Neuroscience Inc
NASDAQ:VIGL |
$375.71 Million | $375.71 Million | USA | $8.05 | +0.00% | +0.00% | 0.00 |
| 455 |
Rocket Pharmaceuticals Inc
NASDAQ:RCKT |
$374.33 Million | $374.33 Million | USA | $3.41 | -0.58% | -11.66% | 33.23 Million |
| 456 |
Fennec Pharmaceuticals Inc
NASDAQ:FENC |
$373.11 Million | $373.11 Million | USA | $10.64 | -0.75% | -14.12% | 6.11 Million |
| 457 |
Ginkgo Bioworks Holdings
NYSE:DNA |
$372.99 Million | $372.99 Million | USA | $6.99 | -0.29% | +0.58% | 27.19 Million |
| 458 |
Checkpoint Therapeutics Inc
NASDAQ:CKPT |
$367.72 Million | $367.72 Million | USA | $4.26 | +0.00% | +0.00% | 8.67 Million |
| 459 |
Zota Health Care LImited
NSE:ZOTA |
$365.14 Million | Rs33.76 Billion | India | Rs1113.10 | +2.38% | -1.70% | 2.34 Million |
| 460 |
Shenzhen Bioeasy Biotechnology Co. Ltd.
SHE:300942 |
$364.55 Million | CN¥2.49 Billion | China | CN¥6.15 | -3.45% | -6.11% | 215.15 Million |
| 461 |
ProKidney Corp.
NASDAQ:PROK |
$363.53 Million | $363.53 Million | USA | $1.74 | -3.87% | -13.43% | 28.84 Million |
| 462 |
Evommune, Inc.
NYSE:EVMN |
$359.82 Million | $359.82 Million | USA | $9.99 | -4.22% | -18.58% | 14.14 Million |
| 463 |
Ocugen Inc
NASDAQ:OCGN |
$358.83 Million | $358.83 Million | USA | $1.06 | +3.92% | -19.70% | 141.50 Million |
| 464 |
Enanta Pharmaceuticals Inc
NASDAQ:ENTA |
$357.95 Million | $357.95 Million | USA | $12.29 | -6.33% | -12.71% | 5.81 Million |
| 465 |
X4 Pharmaceuticals Inc
NASDAQ:XFOR |
$356.93 Million | $356.93 Million | USA | $3.62 | +0.00% | -10.40% | 21.02 Million |
| 466 |
Aclaris Therapeutics Inc
NASDAQ:ACRS |
$353.21 Million | $353.21 Million | USA | $5.53 | -2.04% | -10.45% | 47.76 Million |
| 467 |
Palisade Bio Inc
NASDAQ:PALI |
$350.28 Million | $350.28 Million | USA | $2.02 | -1.71% | -3.59% | 46.40 Million |
| 468 |
Shandong Sito Bio-technology Co Ltd
SHE:300583 |
$349.77 Million | CN¥2.39 Billion | China | CN¥12.60 | -2.85% | -5.76% | 119.35 Million |
| 469 |
Century Therapeutics Inc
NASDAQ:IPSC |
$349.48 Million | $349.48 Million | USA | $1.98 | -1.00% | -6.16% | 9.99 Million |
| 470 |
DiaMedica Therapeutics Inc
NASDAQ:DMAC |
$340.54 Million | $340.54 Million | USA | $6.53 | -0.31% | -3.26% | 3.19 Million |
| 471 |
Keros Therapeutics Inc
NASDAQ:KROS |
$340.31 Million | $340.31 Million | USA | $11.17 | -0.36% | -1.33% | 4.35 Million |
| 472 |
Lexeo Therapeutics, Inc. Common Stock
NASDAQ:LXEO |
$338.85 Million | $338.85 Million | USA | $4.13 | -1.90% | -15.54% | 18.14 Million |
| 473 |
Formycon AG
XETRA:FYB |
$338.61 Million | €289.63 Million | Germany | €20.40 | +2.00% | -0.24% | 127.56K |
| 474 |
Viva Biotech Holdings
F:VB0 |
$337.78 Million | €288.92 Million | Germany | €0.14 | -0.71% | -1.42% | 0.00 |
| 475 |
Circio Holding ASA
OL:CRNA |
$337.48 Million | Nkr3.21 Billion | Norway | Nkr11.70 | -12.69% | -11.63% | 296.08 Million |
| 476 |
Compass Therapeutics Inc.
NASDAQ:CMPX |
$333.16 Million | $333.16 Million | USA | $1.85 | -5.61% | -22.27% | 64.38 Million |
| 477 |
Q32 Bio Inc
NASDAQ:QTTB |
$331.63 Million | $331.63 Million | USA | $11.17 | +2.38% | -6.84% | 12.29 Million |
| 478 |
Jilin Jian Yisheng Pharmaceutical Co Ltd
SHE:002566 |
$328.83 Million | CN¥2.25 Billion | China | CN¥6.79 | -3.41% | -3.69% | 204.82 Million |
| 479 |
Orchestra BioMed Holdings Inc.
NASDAQ:OBIO |
$327.57 Million | $327.57 Million | USA | $6.04 | +2.37% | +18.90% | 8.93 Million |
| 480 |
CHECKPOINT THER. DL-0001
F:CZTA |
$325.84 Million | €278.71 Million | Germany | €3.76 | +0.00% | +0.00% | 3.33K |
| 481 |
Suzhou Fushilai Pharmaceutical Co. Ltd.
SHE:301258 |
$324.62 Million | CN¥2.22 Billion | China | CN¥24.20 | -3.43% | -5.84% | 22.81 Million |
| 482 |
Galectin Therapeutics Inc
NASDAQ:GALT |
$316.67 Million | $316.67 Million | USA | $3.84 | -1.79% | -14.29% | 8.04 Million |
| 483 |
Vicore Pharma Holding AB (publ)
ST:VICO |
$310.84 Million | Skr2.89 Billion | Sweden | Skr10.26 | -3.21% | -6.73% | 20.33 Million |
| 484 |
Abeona Therapeutics Inc
NASDAQ:ABEO |
$310.51 Million | $310.51 Million | USA | $5.43 | +0.18% | -8.74% | 38.47 Million |
| 485 |
SAB Biotherapeutics Inc
NASDAQ:SABS |
$310.26 Million | $310.26 Million | USA | $3.41 | -1.45% | -8.33% | 7.22 Million |
| 486 |
Sionna Therapeutics, Inc. Common Stock
NASDAQ:SION |
$309.59 Million | $309.59 Million | USA | $6.88 | -16.71% | -4.18% | 48.37 Million |
| 487 |
Agenus Inc
NASDAQ:AGEN |
$307.42 Million | $307.42 Million | USA | $7.16 | +0.42% | -13.11% | 24.01 Million |
| 488 |
Jiangsu GDK Biotechnology Co Ltd
SHG:688670 |
$307.38 Million | CN¥2.10 Billion | China | CN¥17.05 | -4.21% | +1.55% | 64.01 Million |
| 489 |
NEWRON PHARMACEUT. EO-20
XETRA:NP5 |
$306.87 Million | €262.49 Million | Germany | €13.15 | +0.77% | -6.41% | 101.13K |
| 490 |
Armata Pharmaceuticals Inc
NYSE MKT:ARMP |
$306.77 Million | $306.77 Million | USA | $8.36 | +1.58% | +1.95% | 1.95 Million |
| 491 |
Medy-Tox Inc
KQ:086900 |
$306.29 Million | ₩451.96 Billion | Korea | ₩68700.00 | -0.15% | -1.01% | 790.56K |
| 492 |
Scpharmaceuticals Inc
NASDAQ:SCPH |
$304.36 Million | $304.36 Million | USA | $5.67 | +0.00% | +0.35% | 34.05 Million |
| 493 |
Eyepoint Pharmaceuticals Inc
NASDAQ:EYPT |
$303.00 Million | $303.00 Million | USA | $3.66 | -13.88% | -20.09% | 154.34 Million |
| 494 |
CLINUVEL PHARMAC.ADRS1
F:UR9A |
$302.25 Million | €258.53 Million | Germany | €5.15 | +0.98% | -2.83% | 924.00 |
| 495 |
Cybin Inc
NEO:CYBN |
$301.37 Million | CA$416.62 Million | Canada | CA$8.35 | -27.89% | -22.40% | 402.95K |
| 496 |
Upstream Bio, Inc.
NASDAQ:UPB |
$300.15 Million | $300.15 Million | USA | $5.48 | -5.68% | -8.82% | 14.41 Million |
| 497 |
Lineage Cell Therapeutics Inc
NYSE MKT:LCTX |
$299.43 Million | $299.43 Million | USA | $1.30 | -1.52% | -0.76% | 31.72 Million |
| 498 |
Clinuvel Pharmaceuticals Ltd
AU:CUV |
$298.29 Million | AU$421.58 Million | Australia | AU$8.36 | +0.60% | +2.45% | 4.06 Million |
| 499 |
Avalo Therapeutics Inc
NASDAQ:AVTX |
$297.50 Million | $297.50 Million | USA | $16.07 | -0.68% | -16.43% | 20.05 Million |
| 500 |
Jiangsu Bioperfectus Technologies Co Ltd
SHG:688399 |
$296.27 Million | CN¥2.02 Billion | China | CN¥24.14 | -2.07% | -9.93% | 36.49 Million |
| 501 |
NervGen Pharma Corp
V:NGEN |
$295.10 Million | CA$407.94 Million | Canada | CA$5.15 | +0.00% | -8.20% | 1.13 Million |
| 502 |
Vanda Pharmaceuticals Inc
NASDAQ:VNDA |
$294.95 Million | $294.95 Million | USA | $4.99 | -3.11% | -8.10% | 18.63 Million |
| 503 |
Green Cross
KO:005250 |
$293.85 Million | ₩433.61 Billion | Korea | ₩9650.00 | -0.31% | -1.73% | 2.69 Million |
| 504 |
Immuneering Corp
NASDAQ:IMRX |
$286.69 Million | $286.69 Million | USA | $4.44 | +2.54% | -7.88% | 16.17 Million |
| 505 |
Guiyang Xintian Pharmaceutical Co Ltd
SHE:002873 |
$284.33 Million | CN¥1.94 Billion | China | CN¥7.96 | -4.33% | -6.90% | 165.73 Million |
| 506 |
Shanghai Hile Bio-tech
SHG:603718 |
$283.95 Million | CN¥1.94 Billion | China | CN¥2.99 | -3.55% | -8.00% | 164.30 Million |
| 507 |
ABEONA THERAPEUT. DL-01
F:PCJ |
$283.22 Million | €242.25 Million | Germany | €4.56 | -1.32% | -8.29% | 4.50K |
| 508 |
NEWRON PHARMACEUT. EO-20
F:NP5 |
$279.73 Million | €239.27 Million | Germany | €11.50 | -0.43% | -9.09% | 1.04K |
| 509 |
AbClon Inc
KQ:174900 |
$279.52 Million | ₩412.46 Billion | Korea | ₩20700.00 | +2.22% | -5.26% | 4.51 Million |
| 510 |
ANTENGENE CORP. DL-0001
F:722 |
$278.87 Million | €238.54 Million | Germany | €0.35 | +1.15% | -1.68% | 0.00 |
| 511 |
Race Oncology Ltd
AU:RAC |
$277.46 Million | AU$392.14 Million | Australia | AU$2.00 | +0.00% | -6.10% | 1.76 Million |
| 512 |
Indaptus Therapeutics Inc
NASDAQ:INDP |
$277.14 Million | $277.14 Million | USA | $3.14 | +13.36% | +168.38% | 37.51 Million |
| 513 |
Dishman Carbogen Amcis Limited
NSE:DCAL |
$276.65 Million | Rs25.58 Billion | India | Rs163.16 | -2.45% | -6.43% | 10.11 Million |
| 514 |
Sutro Biopharma
NASDAQ:STRO |
$274.58 Million | $274.58 Million | USA | $16.56 | -2.07% | -17.49% | 8.30 Million |
| 515 |
AC Immune Ltd
NASDAQ:ACIU |
$272.75 Million | $272.75 Million | USA | $2.68 | +0.75% | -6.29% | 4.58 Million |
| 516 |
Tiansheng Pharmaceutical Group Co Ltd
SHE:002872 |
$268.96 Million | CN¥1.84 Billion | China | CN¥5.78 | -3.18% | -2.53% | 99.46 Million |
| 517 |
2Seventy Bio Inc
NASDAQ:TSVT |
$266.14 Million | $266.14 Million | USA | $5.00 | +0.00% | +0.00% | 0.00 |
| 518 |
Entrada Therapeutics Inc
NASDAQ:TRDA |
$262.95 Million | $262.95 Million | USA | $6.88 | -2.41% | -3.51% | 6.65 Million |
| 519 |
Alx Oncology Holdings
NASDAQ:ALXO |
$261.34 Million | $261.34 Million | USA | $1.89 | -1.82% | -5.97% | 18.54 Million |
| 520 |
ProQR Therapeutics BV
NASDAQ:PRQR |
$259.66 Million | $259.66 Million | USA | $1.84 | -1.08% | -11.11% | 20.54 Million |
| 521 |
Inozyme Pharma Inc
NASDAQ:INZY |
$258.25 Million | $258.25 Million | USA | $4.00 | +0.00% | +0.00% | 0.00 |
| 522 |
Lyell Immunopharma Inc
NASDAQ:LYEL |
$254.51 Million | $254.51 Million | USA | $10.91 | -3.71% | -24.08% | 2.70 Million |
| 523 |
Tanvex BioPharma Inc
TW:6541 |
$252.96 Million | NT$8.03 Billion | Taiwan | NT$30.30 | -1.46% | -4.11% | 9.05 Million |
| 524 |
Starpharma Holdings Ltd
AU:SPL |
$251.47 Million | AU$355.41 Million | Australia | AU$0.75 | +0.68% | -6.29% | 55.95 Million |
| 525 |
Fulcrum Therapeutics Inc
NASDAQ:FULC |
$249.37 Million | $249.37 Million | USA | $3.78 | -0.26% | -1.82% | 39.22 Million |
| 526 |
SILENCE THERAP. SP.ADR/1
F:XRP2 |
$245.62 Million | €210.09 Million | Germany | €7.00 | +10.24% | +40.56% | 5.48K |
| 527 |
Transgene SA
PA:TNG |
$244.86 Million | €209.45 Million | France | €0.86 | -1.94% | -4.33% | 4.17 Million |
| 528 |
Foghorn Therapeutics Inc
NASDAQ:FHTX |
$244.67 Million | $244.67 Million | USA | $4.12 | -5.50% | -16.26% | 9.16 Million |
| 529 |
PharmaEngine
TWO:4162 |
$244.61 Million | NT$7.76 Billion | Taiwan | NT$54.80 | +1.29% | -3.86% | 6.55 Million |
| 530 |
Genfit S.A.
NASDAQ:GNFT |
$244.43 Million | $244.43 Million | USA | $5.97 | +0.00% | -3.71% | 49.82K |
| 531 |
Shattuck Labs Inc
NASDAQ:STTK |
$244.26 Million | $244.26 Million | USA | $5.97 | -3.71% | -12.08% | 19.00 Million |
| 532 |
Newron Pharmaceuticals SpA
SW:NWRN |
$243.84 Million | CHF192.87 Million | Switzerland | CHF10.80 | -2.35% | -8.16% | 1.13 Million |
| 533 |
Zura Bio Limited Class A Ordinary Shares
NASDAQ:ZURA |
$243.84 Million | $243.84 Million | USA | $4.93 | -5.37% | -20.87% | 38.72 Million |
| 534 |
Santhera Pharmaceuticals Holding AG
SW:SANN |
$243.45 Million | CHF192.56 Million | Switzerland | CHF15.58 | +0.13% | +0.78% | 1.73 Million |
| 535 |
Third Harmonic Bio Inc.
NASDAQ:THRD |
$242.79 Million | $242.79 Million | USA | $5.38 | +0.00% | +0.00% | 0.00 |
| 536 |
Anavex Life Sciences Corp
NASDAQ:AVXL |
$240.95 Million | $240.95 Million | USA | $2.60 | -0.76% | -10.03% | 17.15 Million |
| 537 |
Niagen Bioscience, Inc.
NASDAQ:NAGE |
$239.42 Million | $239.42 Million | USA | $3.00 | -1.32% | -5.36% | 9.92 Million |
| 538 |
ADAGENE INC. SP.ADR
F:978 |
$237.92 Million | €203.50 Million | Germany | €3.08 | -2.53% | -2.53% | 3.31K |
| 539 |
Cybin Inc. Common Stock
NYSE MKT:HELP |
$233.50 Million | $233.50 Million | USA | $4.68 | +1.74% | -7.51% | 27.65 Million |
| 540 |
ACELYRIN, INC. Common Stock
NASDAQ:SLRN |
$229.17 Million | $229.17 Million | USA | $2.27 | +0.00% | +0.00% | 0.00 |
| 541 |
NervGen Pharma Corp.
NASDAQ:NGEN |
$229.02 Million | $229.02 Million | USA | $2.14 | -2.51% | -8.15% | 14.05 Million |
| 542 |
AC IMMUNE SA SF-02
F:IMR |
$228.68 Million | €195.60 Million | Germany | €2.26 | -1.10% | -4.45% | 4.90K |
| 543 |
Adimmune Corp
TW:4142 |
$228.41 Million | NT$7.25 Billion | Taiwan | NT$17.20 | +0.00% | -2.82% | 21.79 Million |
| 544 |
Tetratherix Ltd
AU:TTX |
$227.73 Million | AU$321.85 Million | Australia | AU$6.34 | -2.61% | -11.02% | 681.07K |
| 545 |
Greenwich Lifesciences Inc
NASDAQ:GLSI |
$227.51 Million | $227.51 Million | USA | $16.09 | +0.25% | +0.88% | 2.82 Million |
| 546 |
Alector Inc
NASDAQ:ALEC |
$224.59 Million | $224.59 Million | USA | $2.04 | -7.92% | -17.28% | 36.25 Million |
| 547 |
Zentalis Pharmaceuticals Llc
NASDAQ:ZNTL |
$222.81 Million | $222.81 Million | USA | $3.13 | -10.57% | -21.55% | 25.58 Million |
| 548 |
Protara Therapeutics Inc
NASDAQ:TARA |
$221.61 Million | $221.61 Million | USA | $3.75 | -4.09% | -4.82% | 9.36 Million |
| 549 |
MacroGenics Inc
NASDAQ:MGNX |
$218.65 Million | $218.65 Million | USA | $4.04 | -3.81% | -8.18% | 11.71 Million |
| 550 |
CAMP4 THERAPEUTICS CORPORATION
NASDAQ:CAMP |
$217.57 Million | $217.57 Million | USA | $4.19 | -1.41% | -4.99% | 6.82 Million |
| 551 |
CARGO Therapeutics, Inc. Common Stock
NASDAQ:CRGX |
$216.19 Million | $216.19 Million | USA | $4.47 | +0.00% | +0.00% | 0.00 |
| 552 |
Oryzon Genomics SA
MC:ORY |
$214.95 Million | €183.86 Million | Spain | €2.79 | +0.72% | +0.22% | 3.40 Million |
| 553 |
SillaJen Inc
KQ:215600 |
$213.43 Million | ₩314.94 Billion | Korea | ₩2280.00 | +3.17% | -4.60% | 78.39 Million |
| 554 |
Sol Gel Technologies Ltd
NASDAQ:SLGL |
$213.40 Million | $213.40 Million | USA | $65.18 | -1.15% | -7.45% | 1.57 Million |
| 555 |
Cabio Biotech Wuhan Co Ltd
SHG:688089 |
$209.59 Million | CN¥1.43 Billion | China | CN¥8.51 | -2.96% | -4.17% | 48.00 Million |
| 556 |
Eledon Pharmaceuticals Inc
NASDAQ:ELDN |
$209.18 Million | $209.18 Million | USA | $2.71 | -2.17% | -10.26% | 22.60 Million |
| 557 |
Surrozen Inc
NASDAQ:SRZN |
$208.86 Million | $208.86 Million | USA | $17.77 | -0.39% | -21.92% | 4.76 Million |
| 558 |
Invivyd Inc.
NASDAQ:IVVD |
$207.01 Million | $207.01 Million | USA | $0.83 | -6.93% | +0.48% | 95.93 Million |
| 559 |
Coherus BioSciences Inc
NASDAQ:CHRS |
$205.49 Million | $205.49 Million | USA | $1.33 | -6.99% | -6.34% | 25.56 Million |
| 560 |
Thor Medical ASA
OL:TRMED |
$204.51 Million | Nkr1.94 Billion | Norway | Nkr4.60 | -3.16% | -4.86% | 237.33 Million |
| 561 |
SHANDONG BOAN BIOTECH.H 1
F:UJ9 |
$203.72 Million | €174.25 Million | Germany | €0.28 | -5.41% | -16.17% | 0.00 |
| 562 |
AN2 Therapeutics Inc
NASDAQ:ANTX |
$202.27 Million | $202.27 Million | USA | $5.36 | -1.83% | -9.00% | 5.41 Million |
| 563 |
Nkarta Inc
NASDAQ:NKTX |
$201.27 Million | $201.27 Million | USA | $2.88 | -1.37% | -1.37% | 13.30 Million |
| 564 |
Arcturus Therapeutics Holdings Inc
NASDAQ:ARCT |
$201.24 Million | $201.24 Million | USA | $15.84 | +3.60% | +0.13% | 33.08 Million |
| 565 |
Onward Medical N.V.
BR:ONWD |
$200.59 Million | €171.58 Million | Belgium | €2.73 | -0.18% | +9.00% | 4.39 Million |
| 566 |
GENFIT S.A. ADR/1 EO-25
F:XUPB |
$200.59 Million | €171.58 Million | Germany | €5.90 | -4.07% | +9.26% | 252.00 |
| 567 |
PepGen Ltd
NASDAQ:PEPG |
$199.90 Million | $199.90 Million | USA | $2.89 | -2.69% | -7.07% | 17.81 Million |
| 568 |
Satellos Bioscience Inc. Common Stock
NASDAQ:MSLE |
$198.59 Million | $198.59 Million | USA | $9.36 | -4.39% | +4.35% | 641.46K |
| 569 |
Atrys Health SL
MC:ATRY |
$197.39 Million | €168.84 Million | Spain | €2.93 | +5.59% | +17.20% | 906.53K |
| 570 |
Adagene Inc
NASDAQ:ADAG |
$196.24 Million | $196.24 Million | USA | $2.97 | -9.17% | -17.04% | 5.53 Million |
| 571 |
Satellos Bioscience Inc.
TO:MSCL |
$196.05 Million | CA$271.01 Million | Canada | CA$13.01 | -3.70% | +4.50% | 286.23K |
| 572 |
Taigen Biopharmaceuticals Holdings Ltd
TWO:4157 |
$194.89 Million | NT$6.19 Billion | Taiwan | NT$8.69 | +0.23% | -5.23% | 17.74 Million |
| 573 |
Bicycle Therapeutics plc
F:50BA |
$193.16 Million | €165.22 Million | Germany | €3.28 | +0.00% | -7.34% | 2.00K |
| 574 |
ONWARD MEDICAL BV EO -12
F:63E |
$191.55 Million | €163.84 Million | Germany | €2.69 | +0.56% | +9.57% | 2.35K |
| 575 |
SOL-GEL TECHN. IS-10
F:4SG |
$188.25 Million | €161.02 Million | Germany | €65.50 | +9.17% | +6.50% | 1.29K |
| 576 |
Sinphar Pharmaceutical Co Ltd
TW:1734 |
$187.56 Million | NT$5.95 Billion | Taiwan | NT$31.30 | +0.48% | +0.48% | 5.38 Million |
| 577 |
I-MAB SPONS.ADS/1 -0001
F:0VY |
$186.58 Million | €159.59 Million | Germany | €1.38 | +2.22% | -9.21% | 0.00 |
| 578 |
Savior Lifetec
TWO:4167 |
$186.32 Million | NT$5.91 Billion | Taiwan | NT$19.05 | +1.06% | +0.79% | 21.58 Million |
| 579 |
Compugen
TA:CGEN |
$186.23 Million | ILA69.46 Billion | Israel | ILA734.40 | -3.41% | -4.18% | 847.70K |
| 580 |
NovaBridge Biosciences
NASDAQ:NBP |
$183.31 Million | $183.31 Million | USA | $1.59 | -1.24% | -11.67% | 6.23 Million |
| 581 |
Bicycle Therapeutics Ltd
NASDAQ:BCYC |
$183.24 Million | $183.24 Million | USA | $3.67 | -5.66% | -14.65% | 9.27 Million |
| 582 |
Precision BioSciences Inc
NASDAQ:DTIL |
$182.45 Million | $182.45 Million | USA | $6.61 | -3.64% | -11.51% | 6.13 Million |
| 583 |
Minerva Neurosciences Inc
NASDAQ:NERV |
$178.43 Million | $178.43 Million | USA | $3.83 | -4.49% | -13.54% | 3.43 Million |
| 584 |
Biomm S.A
SA:BIOM3 |
$174.53 Million | R$889.47 Million | Brazil | R$6.50 | -0.46% | -1.96% | 765.50K |
| 585 |
Mediwound Ltd
NASDAQ:MDWD |
$172.89 Million | $172.89 Million | USA | $13.47 | -2.95% | +1.35% | 2.70 Million |
| 586 |
Cartesian Therapeutics Inc.
NASDAQ:RNAC |
$172.18 Million | $172.18 Million | USA | $7.89 | -1.87% | -14.89% | 2.80 Million |
| 587 |
Forte Biosciences Inc
NASDAQ:FBRX |
$172.07 Million | $172.07 Million | USA | $76.99 | +0.00% | +0.12% | 58.71 Million |
| 588 |
Voyager Therapeutics Inc
NASDAQ:VYGR |
$171.80 Million | $171.80 Million | USA | $3.09 | -3.13% | -11.97% | 10.23 Million |
| 589 |
MediWound Ltd
F:M8W |
$171.29 Million | €146.52 Million | Germany | €11.40 | -5.00% | +5.56% | 1.82K |
| 590 |
Medigen Biotechnology
TWO:3176 |
$167.00 Million | NT$5.30 Billion | Taiwan | NT$38.05 | +4.25% | +9.50% | 22.42 Million |
| 591 |
Tonix Pharmaceuticals Holding Corp
NASDAQ:TNXP |
$166.63 Million | $166.63 Million | USA | $11.73 | -1.18% | -12.33% | 11.72 Million |
| 592 |
Korro Bio, Inc.
NASDAQ:KRRO |
$165.28 Million | $165.28 Million | USA | $14.07 | +1.37% | +14.95% | 2.37 Million |
| 593 |
Genomictree Inc.
KQ:228760 |
$164.88 Million | ₩243.29 Billion | Korea | ₩10130.00 | +0.50% | -3.98% | 2.03 Million |
| 594 |
Molecular Partners AG ADR
NASDAQ:MOLN |
$164.56 Million | $164.56 Million | USA | $4.40 | +1.38% | +4.76% | 66.47K |
| 595 |
Canton Strategic Holdings, Inc.
NASDAQ:CNTN |
$162.95 Million | $162.95 Million | USA | $2.05 | -2.62% | -10.31% | 14.74 Million |
| 596 |
Bioversys AG
SW:BIOV |
$160.82 Million | CHF127.20 Million | Switzerland | CHF28.20 | +4.44% | +0.71% | 59.10K |
| 597 |
BioInvent International AB
ST:BINV |
$160.04 Million | Skr1.49 Billion | Sweden | Skr22.60 | +1.12% | -4.84% | 2.24 Million |
| 598 |
Jyong Biotech Ltd. Ordinary Shares
NASDAQ:MENS |
$156.62 Million | $156.62 Million | USA | $2.12 | +1.92% | -11.30% | 858.74K |
| 599 |
Atrium Therapeutics, Inc. Common Stock
NASDAQ:RNA |
$156.55 Million | $156.55 Million | USA | $10.09 | -1.18% | -28.89% | 6.51 Million |
| 600 |
Protalix Biotherapeutics Inc
NYSE MKT:PLX |
$156.31 Million | $156.31 Million | USA | $2.10 | +3.45% | +5.00% | 19.50 Million |
Track real-time market capitalization of largest public companies in the Biotechnology industry. Compare marketcap, analyze stock performance, and discover leading biotechnology corporations. View all industries